\-\ Texto\\:\\ \ \(0\)\
\-\ abdomen\\:\\ soft\\,\\ nondistended\\,\\ \\+\\ tenderness\\ to\\ palpation\\ llq\ \(0\)\
\-\ stool\\ occult\\ blood\\ positive\\,\\ fecal\\ leukocytes\\ present\\,\\ wbc\\ within\\ normal\\ limits\\,\\ h\\ pylori\\ ab\\ negative\\,\\ ttg\\ iga\\ negative\\.\\ \\ cea\\ positive\ \(0\)\
\-\ surgical\\ removal\\ of\\ adenocarcinoma\\ with\\ colostomy\\ placed\\.\\ \\ surgical\\ course\\ was\\ complicated\\ with\\ c\\ diff\\ infection\\ post\\ operatively\\.\\ \\ chemotherapy\\ with\\ 5\\-fu\\ \\+\\ leucovorin\\ \\+\\ oxaliplatin\\ \\(flofox\\)\\ initiated\\ soon\\ afterwards\\.\\ \\ plan\\ to\\ reverse\\ colostomy\\ after\\ chemotherapy\\ completed\\.\ \(0\)\
\-\ ct\\ abdomen\\/pelvis\\ with\\ contrast\\:\\ development\\ of\\ at\\ least\\ a\\ partial\\ large\\ bowel\\ obstruction\\ proximal\\ to\\ a\\ focal\\ segment\\ of\\ inflamed\\,\\ thickened\\ sigmoid\\ colon\\.\ \(0\)\
\-\ stage\\ iii\\ t3n1\\ \\(1\\ of\\ 22\\ lymph\\ node\\ positive\\)\\ adenocarinoma\\ of\\ sigmoid\\ colon\ \(0\)\
\-\ crohn\\â\\€\\™s\\,\\ diverticulitis\\,\\ neoplasia\ \(0\)\
\-\ 26\\ y\\/o\\ m\\ who\\ originally\\ presented\\ to\\ outpatient\\ clinic\\ with\\ 1\\ month\\ of\\ llq\\ pain\\ and\\ subjective\\ fevers\\,\\ chills\\,\\ and\\ loose\\ stools\\.\\ \\ pt\\ endorsed\\ 30lb\\ weight\\ loss\\ in\\ past\\ 2\\ months\\.\ \(0\)\
\-\ colorectal\\ cancer\\ is\\ the\\ fourth\\ most\\ common\\ cancer\\ in\\ u\\.s\\.\\ men\\ and\\ women\\ and\\ is\\ the\\ second\\ leading\\ cause\\ of\\ cancer\\ death\\ overall\\.\\ \\ it\\ is\\ very\\ rare\\ under\\ the\\ age\\ of\\ 40\\,\\ with\\ 90\\%\\ of\\ cases\\ occurring\\ after\\ the\\ age\\ of\\ 50\\.\\ \\ approximately\\ 50\\%\\ arise\\ in\\ the\\ rectum\\,\\ 25\\%\\ in\\ the\\ sigmoid\\ colon\\,\\ and\\ 25\\%\\ throughout\\ the\\ remainder\\ of\\ the\\ colon\\.\\ \\ clinical\\ manifestations\\ of\\ distal\\ colon\\ cancer\\ include\\ change\\ in\\ bowel\\ habits\\,\\ obstruction\\,\\ colicky\\ abdominal\\ pain\\,\\ hematochezia\\ and\\ weight\\ loss\\.\\ \\ screening\\ should\\ be\\ performed\\ starting\\ at\\ age\\ 50\\ and\\ repeat\\ every\\ 10\\ years\\ with\\ colonoscopy\\ for\\ average\\ risk\\ individuals\\.\\ \\ those\\ with\\ a\\ positive\\ family\\ history\\ of\\ colon\\ cancer\\ or\\ those\\ with\\ a\\ history\\ of\\ inflammatory\\ bowel\\ disease\\ are\\ at\\ an\\ increased\\ risk\\ and\\ may\\ require\\ earlier\\ and\\ or\\ more\\ frequent\\ screening\\.\\ \\ \ \(0\)\
\-\ nejm\\ 2009\\;361\\:1179\ \(0\)\
\-\ nejm\\ 2004\\;350\\:2343\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ colon\\:\\ 0\\.06392253161566361\ \(0\)\
\-\ cancer\\:\\ 0\\.04458992483118675\ \(0\)\
\-\ \\+\\:\\ 0\\.04198856358764043\ \(0\)\
\-\ sigmoid\\:\\ 0\\.041424860050589665\ \(0\)\
\-\ nejm\\:\\ 0\\.041351957656967954\ \(0\)\
\-\ colostomy\\:\\ 0\\.040194360470974584\ \(0\)\
\-\ llq\\:\\ 0\\.037276694887619415\ \(0\)\
\-\ positive\\:\\ 0\\.03521124559090942\ \(0\)\
\-\ ttg\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ leucovorin\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ oxaliplatin\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ flofox\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ t3n1\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ 361\\:1179\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ 350\\:2343\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ 5\\-fu\\:\\ 0\\.02578530553462398\ \(0\)\
\-\ 30lb\\:\\ 0\\.02578530553462398\ \(0\)\
\-\ bowel\\:\\ 0\\.025523366979854852\ \(0\)\
\-\ \\%\\:\\ 0\\.025312013121854066\ \(0\)\
\-\ age\\:\\ 0\\.024770574528993398\ \(0\)\
\-\ those\\:\\ 0\\.024687395167043134\ \(0\)\
\-\ adenocarinoma\\:\\ 0\\.02449811471523298\ \(0\)\
\-\ screening\\:\\ 0\\.0231430757392276\ \(0\)\
\-\ 50\\.\\:\\ 0\\.02287644606835682\ \(0\)\
\-\ 25\\:\\ 0\\.0219315952905211\ \(0\)\
\-\ leukocytes\\:\\ 0\\.021808280237813286\ \(0\)\
\-\ operatively\\:\\ 0\\.021808280237813286\ \(0\)\
\-\ endorsed\\:\\ 0\\.021808280237813286\ \(0\)\
\-\ iga\\:\\ 0\\.021010456655969137\ \(0\)\
\-\ habits\\:\\ 0\\.021010456655969137\ \(0\)\
\-\ u\\.s\\:\\ 0\\.020675978828483977\ \(0\)\
\-\ 50\\:\\ 0\\.020641257248532094\ \(0\)\
\-\ afterwards\\:\\ 0\\.020373406829105167\ \(0\)\
\-\ diff\\:\\ 0\\.020097180235487292\ \(0\)\
\-\ pylori\\:\\ 0\\.01984307640160305\ \(0\)\
\-\ risk\\:\\ 0\\.019652105697518008\ \(0\)\
\-\ cea\\:\\ 0\\.019607812997940444\ \(0\)\
\-\ reverse\\:\\ 0\\.019607812997940444\ \(0\)\
\-\ colorectal\\:\\ 0\\.019607812997940444\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01944727482629121\ \(0\)\
\-\ weight\\:\\ 0\\.01944727482629121\ \(0\)\
\-\ fecal\\:\\ 0\\.019388788009092977\ \(0\)\
\-\ colicky\\:\\ 0\\.019388788009092977\ \(0\)\
\-\ hematochezia\\:\\ 0\\.019388788009092977\ \(0\)\
\-\ obstruction\\:\\ 0\\.019132698721202764\ \(0\)\
\-\ inflamed\\:\\ 0\\.0188099894160963\ \(0\)\
\-\ neoplasia\\:\\ 0\\.0188099894160963\ \(0\)\
\-\ ab\\:\\ 0\\.018320622178549444\ \(0\)\
\-\ stools\\:\\ 0\\.018031822882658248\ \(0\)\
\-\ abdomen\\/pelvis\\:\\ 0\\.01789671299561445\ \(0\)\
\-\ subjective\\:\\ 0\\.01789671299561445\ \(0\)\
\-\ nondistended\\:\\ 0\\.01764260916173021\ \(0\)\
\-\ starting\\:\\ 0\\.017295944742793726\ \(0\)\
\-\ 2009\\:\\ 0\\.017295944742793726\ \(0\)\
\-\ soon\\:\\ 0\\.016983436575132606\ \(0\)\
\-\ initiated\\:\\ 0\\.016698953531673284\ \(0\)\
\-\ plan\\:\\ 0\\.016609522176223454\ \(0\)\
\-\ occult\\:\\ 0\\.016355418342339213\ \(0\)\
\-\ negative\\:\\ 0\\.016203937532538886\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.015831355642785407\ \(0\)\
\-\ average\\:\\ 0\\.015831355642785407\ \(0\)\
\-\ individuals\\:\\ 0\\.015831355642785407\ \(0\)\
\-\ loose\\:\\ 0\\.01576308197541727\ \(0\)\
\-\ loss\\:\\ 0\\.01574897887281549\ \(0\)\
\-\ completed\\:\\ 0\\.01563078770112975\ \(0\)\
\-\ outpatient\\:\\ 0\\.015442141921857366\ \(0\)\
\-\ manifestations\\:\\ 0\\.015442141921857366\ \(0\)\
\-\ originally\\:\\ 0\\.015322331356832456\ \(0\)\
\-\ men\\:\\ 0\\.015322331356832456\ \(0\)\
\-\ occurring\\:\\ 0\\.015150689384545868\ \(0\)\
\-\ rectum\\:\\ 0\\.015150689384545868\ \(0\)\
\-\ stool\\:\\ 0\\.014935379554899006\ \(0\)\
\-\ death\\:\\ 0\\.014637542236747722\ \(0\)\
\-\ \\,\\:\\ 0\\.014609749567599637\ \(0\)\
\-\ 2004\\:\\ 0\\.014590510218382195\ \(0\)\
\-\ crohn\\:\\ 0\\.014498486291800441\ \(0\)\
\-\ every\\:\\ 0\\.014409054936350613\ \(0\)\
\-\ h\\:\\ 0\\.014279461302952979\ \(0\)\
\-\ complicated\\:\\ 0\\.014074577108865447\ \(0\)\
\-\ m\\:\\ 0\\.01399618786254681\ \(0\)\
\-\ diverticulitis\\:\\ 0\\.01391968769880376\ \(0\)\
\-\ least\\:\\ 0\\.013596568034327752\ \(0\)\
\-\ chills\\:\\ 0\\.013562614735544426\ \(0\)\
\-\ frequent\\:\\ 0\\.013562614735544426\ \(0\)\
\-\ overall\\:\\ 0\\.01349577851586877\ \(0\)\
\-\ arise\\:\\ 0\\.013430320461256908\ \(0\)\
\-\ earlier\\:\\ 0\\.013398090710577487\ \(0\)\
\-\ women\\:\\ 0\\.0131812042217601\ \(0\)\
\-\ fourth\\:\\ 0\\.013121864116959614\ \(0\)\
\-\ leading\\:\\ 0\\.012978192397632246\ \(0\)\
\-\ 1\\:\\ 0\\.012910008685458456\ \(0\)\
\-\ c\\:\\ 0\\.012895010263048044\ \(0\)\
\-\ fevers\\:\\ 0\\.012895010263048044\ \(0\)\
\-\ \\;\\:\\ 0\\.012859817069540277\ \(0\)\
\-\ 90\\:\\ 0\\.012787386289474453\ \(0\)\
\-\ remainder\\:\\ 0\\.012787386289474453\ \(0\)\
\-\ repeat\\:\\ 0\\.012761040883713513\ \(0\)\
\-\ iii\\:\\ 0\\.012734912315026164\ \(0\)\
\-\ 26\\:\\ 0\\.012557796887634368\ \(0\)\
\-\ node\\:\\ 0\\.012413471890565297\ \(0\)\
\-\ require\\:\\ 0\\.012413471890565297\ \(0\)\
\-\ thickened\\:\\ 0\\.012164799372248134\ \(0\)\
\-\ clinic\\:\\ 0\\.012121606826039312\ \(0\)\
\-\ 22\\:\\ 0\\.012100228946098537\ \(0\)\
\-\ under\\:\\ 0\\.011854330345974716\ \(0\)\
\-\ segment\\:\\ 0\\.011834673297568616\ \(0\)\
\-\ development\\:\\ 0\\.011815137216380115\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.011719220458930918\ \(0\)\
\-\ stage\\:\\ 0\\.0115715378696138\ \(0\)\
\-\ 40\\:\\ 0\\.011413214599644995\ \(0\)\
\-\ surgical\\:\\ 0\\.011404582668263196\ \(0\)\
\-\ after\\:\\ 0\\.011225404461010809\ \(0\)\
\-\ limits\\:\\ 0\\.011181630473784147\ \(0\)\
\-\ family\\:\\ 0\\.011118452206110192\ \(0\)\
\-\ at\\:\\ 0\\.011026315741253649\ \(0\)\
\-\ placed\\:\\ 0\\.010980736981887255\ \(0\)\
\-\ lymph\\:\\ 0\\.010950928282363957\ \(0\)\
\-\ partial\\:\\ 0\\.010848748325234112\ \(0\)\
\-\ removal\\:\\ 0\\.0106945430231752\ \(0\)\
\-\ change\\:\\ 0\\.010573719017383628\ \(0\)\
\-\ rare\\:\\ 0\\.010534445075153321\ \(0\)\
\-\ second\\:\\ 0\\.010419456937266596\ \(0\)\
\-\ course\\:\\ 0\\.010236607757002036\ \(0\)\
\-\ throughout\\:\\ 0\\.010154753416825164\ \(0\)\
\-\ pt\\:\\ 0\\.010086234141691278\ \(0\)\
\-\ wbc\\:\\ 0\\.009889126509764482\ \(0\)\
\-\ very\\:\\ 0\\.009846938471292473\ \(0\)\
\-\ inflammatory\\:\\ 0\\.009407352203784202\ \(0\)\
\-\ cause\\:\\ 0\\.009178611512863385\ \(0\)\
\-\ 10\\:\\ 0\\.009144838820148922\ \(0\)\
\-\ palpation\\:\\ 0\\.009053774858247784\ \(0\)\
\-\ cases\\:\\ 0\\.00903749480628931\ \(0\)\
\-\ should\\:\\ 0\\.008648281085361269\ \(0\)\
\-\ past\\:\\ 0\\.008619680863322012\ \(0\)\
\-\ post\\:\\ 0\\.008542333438324742\ \(0\)\
\-\ approximately\\:\\ 0\\.00839307246525582\ \(0\)\
\-\ clinical\\:\\ 0\\.008347015238304775\ \(0\)\
\-\ tenderness\\:\\ 0\\.008250515310735344\ \(0\)\
\-\ proximal\\:\\ 0\\.008144581529228619\ \(0\)\
\-\ month\\:\\ 0\\.008138458859684474\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.00810802139569986\ \(0\)\
\-\ abdomen\\:\\ 0\\.008036140517129194\ \(0\)\
\-\ years\\:\\ 0\\.007965851228630102\ \(0\)\
\-\ infection\\:\\ 0\\.007885766901818435\ \(0\)\
\-\ s\\:\\ 0\\.0077802148162367845\ \(0\)\
\-\ focal\\:\\ 0\\.007747598743296514\ \(0\)\
\-\ include\\:\\ 0\\.0076100110731120215\ \(0\)\
\-\ performed\\:\\ 0\\.007563740734054981\ \(0\)\
\-\ y\\/o\\:\\ 0\\.007513108031173462\ \(0\)\
\-\ history\\:\\ 0\\.00749342563623545\ \(0\)\
\-\ months\\:\\ 0\\.007409337443460531\ \(0\)\
\-\ blood\\:\\ 0\\.007404479595267618\ \(0\)\
\-\ presented\\:\\ 0\\.007394786142928283\ \(0\)\
\-\ distal\\:\\ 0\\.007375487583955641\ \(0\)\
\-\ \\:\\:\\ 0\\.007176348038035968\ \(0\)\
\-\ common\\:\\ 0\\.007099260990337769\ \(0\)\
\-\ who\\:\\ 0\\.007072915584576832\ \(0\)\
\-\ more\\:\\ 0\\.006784686696229099\ \(0\)\
\-\ abdominal\\:\\ 0\\.0067806959940384616\ \(0\)\
\-\ in\\:\\ 0\\.006688844922861189\ \(0\)\
\-\ increased\\:\\ 0\\.006636459624760812\ \(0\)\
\-\ pain\\:\\ 0\\.006626083603369744\ \(0\)\
\-\ soft\\:\\ 0\\.006606116711090635\ \(0\)\
\-\ or\\:\\ 0\\.006358874596594968\ \(0\)\
\-\ most\\:\\ 0\\.0062629687038986545\ \(0\)\
\-\ present\\:\\ 0\\.006127011917243431\ \(0\)\
\-\ it\\:\\ 0\\.006097931379469894\ \(0\)\
\-\ contrast\\:\\ 0\\.006072303767644144\ \(0\)\
\-\ may\\:\\ 0\\.005950248790152774\ \(0\)\
\-\ large\\:\\ 0\\.005931880735971682\ \(0\)\
\-\ 2\\:\\ 0\\.005841601576223956\ \(0\)\
\-\ to\\:\\ 0\\.005423087091339508\ \(0\)\
\-\ is\\:\\ 0\\.005355150270330721\ \(0\)\
\-\ of\\:\\ 0\\.005177946702132819\ \(0\)\
\-\ within\\:\\ 0\\.0051750203440827985\ \(0\)\
\-\ and\\:\\ 0\\.005143114449491956\ \(0\)\
\-\ a\\:\\ 0\\.005036187959601286\ \(0\)\
\-\ \\(\\:\\ 0\\.004586423658691178\ \(0\)\
\-\ \\)\\:\\ 0\\.004530398045163842\ \(0\)\
\-\ disease\\:\\ 0\\.004434087432430807\ \(0\)\
\-\ normal\\:\\ 0\\.004252737951108258\ \(0\)\
\-\ be\\:\\ 0\\.004183354677282315\ \(0\)\
\-\ ct\\:\\ 0\\.003794614772673152\ \(0\)\
\-\ an\\:\\ 0\\.003751317029475333\ \(0\)\
\-\ are\\:\\ 0\\.0036980122937447673\ \(0\)\
\-\ the\\:\\ 0\\.0035110929448539884\ \(0\)\
\-\ with\\:\\ 0\\.003342976459711135\ \(0\)\
\-\ was\\:\\ 0\\.0031373889594085297\ \(0\)\
\-\ for\\:\\ 0\\.002314629043310207\ \(0\)\
\-\ \\.\\:\\ 0\\.0015777571598820568\ \(0\)\
